Literature DB >> 9494081

Intestinal maturation in mice lacking CCAAT/enhancer-binding protein alpha (C/EPBalpha).

T J Oesterreicher1, L L Leeper, M J Finegold, G J Darlington, S J Henning.   

Abstract

In rodents, there is a surge of intestinal expression of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in the late fetal phase just before morphological maturation and the onset of expression of numerous epithelial genes. To investigate directly the hypothesis that C/EBPalpha plays a causal role in the latter phenomena, we have assessed both structural and functional maturation in neonatal intestine from C/EBPalpha-null mice and their littermates. No effects of C/EBPalpha genotype were observed on mucosal architecture or on the size of the proliferative zone in the intestinal crypts. Likewise, the mRNA levels for the glucose transporter 2 (GLUT2), intestinal and liver fatty acid-binding proteins, and apolipoprotein A-IV in newborn intestine were similar in all genotypes. Paradoxically, Na+/glucose co-transporter (SGLT1), lactase phlorizin-hydrolase and apolipoprotein B mRNAs were more abundant in the C/EBPalpha-deficient animals. In wild-type intestines, C/EBPbeta and C/EBPdelta mRNAs were detectable throughout the late fetal period and increased toward term in parallel with C/EBPalpha mRNA. In newborn intestine, there was no compensatory up-regulation of these isoforms in the C/EBPalpha-deficient mice. We conclude that C/EBPalpha has no essential role in morphological maturation of the intestine, the pattern of proliferation of the epithelium, or the onset of expression of this cluster of epithelial mRNAs. However, since other C/EBP isoforms are present in the developing intestine, it is possible that there is a generic requirement for a member of the C/EBP family.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9494081      PMCID: PMC1219257          DOI: 10.1042/bj3301165

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

Review 1.  Molecular genetics of intestinal glucose transport.

Authors:  E M Wright; E Turk; B Zabel; S Mundlos; J Dyer
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

2.  Growth-dependent inhibition of CCAAT enhancer-binding protein (C/EBP alpha) gene expression during hepatocyte proliferation in the regenerating liver and in culture.

Authors:  D Mischoulon; B Rana; N L Bucher; S R Farmer
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

3.  GLUT2 is the transporter for fructose across the rat intestinal basolateral membrane.

Authors:  C I Cheeseman
Journal:  Gastroenterology       Date:  1993-10       Impact factor: 22.682

4.  The high affinity Na+/glucose cotransporter. Re-evaluation of function and distribution of expression.

Authors:  W S Lee; Y Kanai; R G Wells; M A Hediger
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

5.  CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program.

Authors:  F T Lin; M D Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

6.  Use of transgenic mice to map cis-acting elements in the liver fatty acid-binding protein gene (Fabpl) that regulate its cell lineage-specific, differentiation-dependent, and spatial patterns of expression in the gut epithelium and in the liver acinus.

Authors:  T C Simon; K A Roth; J I Gordon
Journal:  J Biol Chem       Date:  1993-08-25       Impact factor: 5.157

7.  Lactase gene expression during early development of rat small intestine.

Authors:  E H Rings; P A de Boer; A F Moorman; E H van Beers; J Dekker; R K Montgomery; R J Grand; H A Büller
Journal:  Gastroenterology       Date:  1992-10       Impact factor: 22.682

8.  Cell lineage-specific and differentiation-dependent patterns of CCAAT/enhancer binding protein alpha expression in the gut epithelium of normal and transgenic mice.

Authors:  C Chandrasekaran; J I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

9.  Small intestine hexose transport in experimental diabetes. Increased transporter mRNA and protein expression in enterocytes.

Authors:  C F Burant; S Flink; A M DePaoli; J Chen; W S Lee; M A Hediger; J B Buse; E B Chang
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

10.  Use of transgenic mice to map cis-acting elements in the intestinal fatty acid binding protein gene (Fabpi) that control its cell lineage-specific and regional patterns of expression along the duodenal-colonic and crypt-villus axes of the gut epithelium.

Authors:  S M Cohn; T C Simon; K A Roth; E H Birkenmeier; J I Gordon
Journal:  J Cell Biol       Date:  1992-10       Impact factor: 10.539

View more
  2 in total

1.  Platelet-activating factor and endotoxin activate CCAAT/enhancer binding protein in rat small intestine.

Authors:  H Wang; X Qu; I G De Plaen; W Hsueh
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

2.  Exfoliated epithelial cell transcriptome reflects both small and large intestinal cell signatures in piglets.

Authors:  Grace Yoon; Laurie A Davidson; Jennifer S Goldsby; Destiny A Mullens; Ivan Ivanov; Sharon M Donovan; Robert S Chapkin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-05-05       Impact factor: 4.871

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.